Sections
| Title | Starting Page | Number of Pages |
|---|
| Cover Page | 1 | 1 |
| List of Contents and Tables | 2 | 1 |
| Table/Chart: 1 | 2 | 1 |
| Table/Chart: Tabular Data Analysis | 2 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 3 | 1 |
| NRT Smoking Cessation Aids in Spain - Category Analysis | 4 | 1 |
| KEY DATA FINDINGS | 4 | 1 |
| 2025 DEVELOPMENTS | 4 | 1 |
| Category maturity and legislation negatively impact performance | 4 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 5 | 1 |
| Nicorette dominates a consolidated field but champix's return may disrupt the competitive landscape | 5 | 1 |
| Pharmacies remain the key point of purchase | 5 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 6 | 1 |
| PROSPECTS and OPPORTUNITIES | 6 | 1 |
| Reimbursement legislation is set to continue to hinder otc demand | 6 | 1 |
| Most smokers looking to quit the habit avoid nrt smoking cessation aids | 6 | 1 |
| Rating vaping culture offers players opportunities to diversify | 6 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 7 | 1 |
| CATEGORY INDICATORS | 7 | 1 |
| CATEGORY DATA | 7 | 1 |
| Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2020-2025 | 7 | 1 |
| Table/Chart: Table 1 Number of Smokers by Gender 2020-2025 | 7 | 1 |
| Table/Chart: Tabular Data Analysis | 7 | 1 |
| Table/Chart: EUR million | 7 | 1 |
| Table/Chart: % current value growth | 7 | 1 |
| Table/Chart: Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2021-2025 | 7 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 8 | 1 |
| Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2025-2030 | 8 | 1 |
| Table/Chart: Tabular Data Analysis | 8 | 1 |
| Table/Chart: Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2022-2025 | 8 | 1 |
| Table/Chart: EUR million | 8 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 9 | 1 |
| Graph - Note: 2025 data is provisional and based on part-year estimates | 9 | 1 |
| Table/Chart: Tabular Data Analysis | 9 | 1 |
| Consumer Health in Spain - Industry Overview | 10 | 1 |
| EXECUTIVE SUMMARY | 10 | 1 |
| Key trends in 2025 | 10 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 11 | 1 |
| Competitive landscape | 11 | 1 |
| Channel developments | 11 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 12 | 1 |
| What next for consumer health? | 12 | 1 |
| MARKET INDICATORS | 12 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 13 | 1 |
| MARKET DATA | 13 | 1 |
| Table 10 Sales of Consumer Health by Category: Value 2020-2025 | 13 | 1 |
| Table/Chart: Tabular Data Analysis | 13 | 1 |
| Table/Chart: Table 9 Life Expectancy at Birth 2020-2025 | 13 | 1 |
| Table/Chart: EUR million | 13 | 1 |
| Table/Chart: Table 11 Sales of Consumer Health by Category: % Value Growth 2020-2025 | 13 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 14 | 1 |
| Table 13 LBN Brand Shares of Consumer Health: % Value 2022-2025 | 14 | 1 |
| Table/Chart: Tabular Data Analysis | 14 | 1 |
| Table/Chart: Table 12 NBO Company Shares of Consumer Health: % Value 2021-2025 | 14 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 15 | 1 |
| Table/Chart: Tabular Data Analysis | 15 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 16 | 1 |
| Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2020-2025 | 16 | 1 |
| Table 15 Distribution of Consumer Health by Format: % Value 2020-2025 | 16 | 1 |
| Table/Chart: Tabular Data Analysis | 16 | 1 |
| Table/Chart: % retail value rsp | 16 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 17 | 1 |
| Table 16 Distribution of Consumer Health by Format and Category: % Value 2025 | 17 | 1 |
| Table/Chart: Tabular Data Analysis | 17 | 1 |
| Table/Chart: % retail value rsp | 17 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 18 | 1 |
| Table/Chart: Tabular Data Analysis | 18 | 1 |
| Table/Chart: Table 17 Forecast Sales of Consumer Health by Category: Value 2025-2030 | 18 | 1 |
| NRT SMOKING CESSATION AIDS IN SPAIN | 19 | 1 |
| Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2025-2030 | 19 | 1 |
| APPENDIX | 19 | 1 |
| Otc registration and classification | 19 | 1 |
| Table/Chart: Tabular Data Analysis | 19 | 1 |
| Table/Chart: % constant value growth | 19 | 1 |
| Vitamins and dietary supplements registration and classification | 20 | 1 |
| Disclosure | 21 | 1 |
| Table/Chart: Tabular Data Analysis | 21 | 1 |
| Disclosure | 22 | 1 |
| Graph - Summary 2 Research Sources | 22 | 1 |
| Table/Chart: Summary 2 Research Sources | 22 | 1 |
| Table/Chart: Tabular Data Analysis | 22 | 1 |
| Disclosure | 23 | 1 |
